NOVARTIS AG (NVSEF)
Clinical trial NCT07550517 updates: 1. start date: 2026-07-01 → 2026-08-01 2. completion date: 2033-07-01 → 2033-08-01 3. primary completion date: 2032-07-01 → 2032-08-01
Clinical trial NCT07550517 updates: 1. start date: 2026-07-01 → 2026-08-01 2. completion date: 2033-07-01 → 2033-08-01 3. primary completion date: 2032-07-01 → 2032-08-01
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical